臧敬五博士于2016年創(chuàng)立天境生物，現(xiàn)任天境生物董事長。在他的領(lǐng)導(dǎo)下，天境生物在短短五年內(nèi)迅速建立起擁有十多個具有全球競爭力的創(chuàng)新藥研發(fā)管線，并成功在美國納斯達(dá)克上市，天境生物目前正快速成長為覆蓋全產(chǎn)業(yè)鏈的綜合性全球生物制藥公司。
臧敬五博士曾先后在跨國醫(yī)藥公司和中國藥企擔(dān)任高級管理職務(wù), 包括葛蘭素史克（GSK）全球高級副總裁兼全球神經(jīng)系統(tǒng)治療領(lǐng)域負(fù)責(zé)人及中國研發(fā)中心負(fù)責(zé)人，先聲藥業(yè)集團(tuán)首席科學(xué)官和百家匯總裁。在進(jìn)入藥企之前，臧敬五博士曾任美國貝勒醫(yī)學(xué)院（Baylor College of Medicine）免疫學(xué)及神經(jīng)學(xué)教授。回國后，臧敬五博士參與創(chuàng)建了中國科學(xué)院健康科學(xué)研究所和上海巴斯德研究所并擔(dān)任兩家研究所的首任所長，他還曾任上海市免疫學(xué)研究所所長、上海交大醫(yī)學(xué)院基礎(chǔ)醫(yī)學(xué)院院長等職務(wù)。
臧敬五博士畢業(yè)于上海第二醫(yī)科大學(xué)（現(xiàn)上海交通大學(xué)醫(yī)學(xué)院），布魯塞爾大學(xué)免疫學(xué)博士，美國哈佛醫(yī)學(xué)院免疫學(xué)博士后。在國際頂尖和知名學(xué)術(shù)期刊上共發(fā)表130余篇論文、綜述及專著。臧敬五博士在美國貝勒醫(yī)學(xué)院完成住院醫(yī)師規(guī)培并持美國德州職業(yè)醫(yī)師執(zhí)照（Texas Medical Board）。
?
Dr. Zang founded I-Mab in 2016 and brought the Company to NASDAQ in early 2020. Under his leadership, I-Mab has evolved from an early-stage discovery company into a clinical stage company with an innovative and globally competitive pipeline in only four years.
Prior to founding I-Mab, Dr. Zang held various senior executive positions in global and China pharma groups, including Senior Vice President and head of Neuroscience Therapeutic Area and head of China R&D Center with GlaxoSmithKline and Chief Scientific Officer and President with Simcere Pharmaceuticals and BioSciKin, an innovative drug development platform.
Dr. Zang started his academic pursuit at Dr. L. Willems Institute in Belgium where he was head of multiple sclerosis research unit and later became Professor of Neurology and Immunology and Research Director of Multiple Sclerosis Center at Baylor College of Medicine in US. During his academic career in China, Dr. Zang founded the Institute of Health Sciences and co-founded the Institute Pasteur Shanghai with the Chinese Academy of Sciences. He also served as Dean of School of Medical Sciences at the Shanghai JiaoTong University and Director of Shanghai Institute of Immunology. Dr. Zang published more than 130 scientific articles and book chapters in prestigious journals and publications, including in?Science,?Nature Medicine,?Nature Immunology, Immunity.
Dr. Zang received his medical degree from Shanghai JiaoTong University School of Medicine, Ph.D. in Immunology from University of Brussels and completed his postdoctoral fellowship at Harvard Medical School. Dr. Zang is a licensed physician (Texas Medical Board) in US.